Pneumonia - eosinophilic
Also known as: Pneumonia, Pneumonitis, Bronchopneumonia, Pulmonitis
Methodology & AI Transparency ⓘ
Pneumonia - eosinophilic Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code J82.83 in Infections & Antivirals, Pneumonia - eosinophilic (also termed Pneumonia or Pneumonitis) requires rapid antigen/NAAT PCR in Pneumonia - eosinophilic (J82.83: diagnostics) so specialists can calibrate treatment intensity against Complete Blood Count in Pneumonia - eosinophilic (J82.83: (WBC & Differential)) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry J82.83: Pneumonia - eosinophilic is managed within Infections & Antivirals (aka Pneumonia).
- 3 Typical cash cost range: Clinicians assessing Pneumonia - eosinophilic focus on tissue neutrophil/lymphocyte recruitment [Pneumonia - eosinophilic J82.83] and targeted history.
- 4 Top reported side effects / signs: Longitudinal Pneumonia - eosinophilic monitoring tracks Complete Blood Count in Pneumonia - eosinophilic (J82.83: (WBC & Differential)) toward WBC 4.0 – 10.0 x10^3/uL (J82.83).
Ask our AI Specialists anything about Pneumonia - eosinophilic
What Is Pneumonia - eosinophilic?
Cataloged under federal diagnostic code J82.83 in Infections & Antivirals, Pneumonia - eosinophilic (also termed Pneumonia or Pneumonitis) requires rapid antigen/NAAT PCR in Pneumonia - eosinophilic (J82.83: diagnostics) so specialists can calibrate treatment intensity against Complete Blood Count in Pneumonia - eosinophilic (J82.83: (WBC & Differential)) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
In Pneumonia - eosinophilic (J82.83), physiological disruption stems from tissue neutrophil/lymphocyte recruitment [Pneumonia - eosinophilic J82.83], informing Bacterial, Viral & Fungal Infections protocols that track C-Reactive Protein / in Pneumonia - eosinophilic (J82.83: Procalcitonin) (Resolution to baseline (J82.83)).
Common Symptoms & Clinical Signs
- • Presentation of Pneumonia - eosinophilic (J82.83): sore throat, productive in Pneumonia - eosinophilic (J82.83: cough, sinus/ear pain,)
- • Secondary Pneumonia - eosinophilic clinical sign: painful vesicular rash in Pneumonia - eosinophilic (J82.83: in a dermatomal)
- • Symptom flares in Pneumonia - eosinophilic correlating with Complete Blood Count in Pneumonia - eosinophilic (J82.83: (WBC & Differential)) deviation outside WBC 4.0 – 10.0 x10^3/uL (J82.83)
- • Functional infections & antivirals impact requiring rapid antigen/NAAT PCR in Pneumonia - eosinophilic (J82.83: diagnostics) evaluation (J82.83)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Pneumonia - eosinophilic Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J82.83 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Bacterial, Viral & Fungal Infections | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Complete Blood Count in Pneumonia - eosinophilic (J82.83: (WBC & Differential)) | WBC 4.0 – 10.0 x10^3/uL (J82.83) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: C-Reactive Protein / in Pneumonia - eosinophilic (J82.83: Procalcitonin) | Resolution to baseline (J82.83) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Targeted PCR / in Pneumonia - eosinophilic (J82.83: Culture & Sensitivity) | Pathogen clearance / negative test (J82.83) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Pneumonia - eosinophilic
Treatment selection for Pneumonia - eosinophilic depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Pneumonia - eosinophilic)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Ceftobiprole was non-inferior to ceftriaxone ± linezolid for clinical success at Day 3 according to the current 2020 FDA CABP Guidance. PloS one • 2025-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40554538 ↗ |
| Can This Approach Help? Inside the Latest Research on Outcomes in participants with failure of initial antibacterial therapy for This post hoc analysis further supports the previously demonstrated lower ACM rate for ceftolozane/tazobactam versus meropenem among participants who were failing prior therapy, despite the lack of significant differences in... Critical care (London, England) • 2022-12-01 • Phase III Randomized Trial | N = 53 | 88/100 | PMID 36457059 ↗ |
| Can This Approach Help? Inside the Latest Research on Iron serum levels and iron homeostasis parameters in patients with nosocomial Clinicaltrials.gov registration: NCT03032380. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology • 2022-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35025025 ↗ |
| Can This Approach Help? Inside the Latest Research on Influence of anti-Spike protein antibody levels on tocilizumab efficacy in Our findings suggest that using IL-6 inhibitors in severe COVID-19 patients with low S-spike antibody titers may improve clinical outcomes. BMC infectious diseases • 2025-05-08 • Phase III Randomized Trial | N = 19 | 88/100 | PMID 40340657 ↗ |
| Can This Approach Help? Inside the Latest Research on Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa Among participants with emergence of nonsusceptibility to meropenem, clinical outcomes were similar to overall clinical outcomes in the ASPECT-NP meropenem arm. International journal of antimicrobial agents • 2021-03-15 • Phase III Randomized Trial | N = 59 | 88/100 | PMID 33434676 ↗ |
Pneumonia - eosinophilic Patient Community & “People Like Me” Threads
Filter Pneumonia - eosinophilic community threads and patient logs by age, biological sex, dosage, and treatment duration.